| Name | Zinc Sulfate |
| Uses | Essential trace mineral used to support immune function, wound healing, skin health, and antioxidant activity. In wellness settings, zinc sulfate may be included in IV formulations for immune support, skin health, and addressing mild dietary deficiencies. |
| Route Of Administration | Intravenous (IV) |
| Frequency Of Use | Typically administered once every 2 to 4 weeks for general wellness and immune support. Frequency should be reassessed after 8 to 12 weeks based on clinical assessment. |
| Concentration(s) | Common concentration: 5 mg/mL (elemental zinc). Final concentration depends on compounded formulation. |
| Maximum Dosage (Day, Wk) (g/mL)/mL | Maximum dose per infusion: 25 mg elemental zinc. Maximum weekly dose: 25 mg. Higher doses increase risk of nausea and zinc toxicity (copper deficiency with long-term excessive zinc use). |
| Contraindications | Severe renal impairment. Known hypersensitivity to zinc sulfate or any formulation component. Caution in patients with known copper deficiency (prolonged zinc supplementation may worsen copper depletion). Pregnancy and breastfeeding unless cleared by OB provider. |
| Possible Side Effects | Nausea, metallic taste, or transient dizziness during infusion. Injection site irritation. Rare: allergic reaction (rash, itching, hypersensitivity). High doses may cause gastric upset or copper deficiency with prolonged use. |
| Compatibility With Other Drugs | Compatible with normal saline and D5W. May be combined with vitamins, minerals, and amino acids in comprehensive wellness IVs, but compatibility should always be verified before mixing. |
| Allergies | True allergy to zinc is rare, but sensitivity to preservatives or stabilizers in compounded formulations is possible. |
| Administration Time | Typical infusion time: 30 to 60 minutes when part of a multi-nutrient IV formulation. |
| IV Dosing | For general wellness and immune support: 10 mg to 25 mg elemental zinc IV every 2 to 4 weeks, adjusted based on clinical need and dietary intake. |
| IM/Push | Not recommended for IM or IV push due to potential for vein irritation and nausea. Controlled IV infusion is preferred. |
| What To Do If Adverse Reaction Occurs | 1. Stop the infusion immediately if a reaction occurs. 2. Assess vital signs (blood pressure, heart rate, oxygen saturation). 3. If nausea, dizziness, or metallic taste occurs, slow the infusion rate and provide supportive care. 4. For allergic reactions (rash, itching, shortness of breath), administer antihistamines and consider epinephrine if severe. 5. If symptoms persist or worsen, arrange for emergency transfer to a higher level of care (call 911 if necessary). |